$Acumen Pharmaceuticals(ABOS.US)$ NEWS Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting Sabirnetug demonstrated a favorable safety profile with low incidence of ARIA-E in early AD participants. Target engagement with AβOs in cerebrospinal fluid increased in a dose-dependent manner, suggesting active removal of target from the brain. Sabirnetug treatment led to changes in CSF and plasma bio...
$Acumen Pharmaceuticals(ABOS.US)$Acumen Pharmaceuticals Collaborates With Lonza Covering The Manufacture Of Sabirnetug (ACU193) For Alzheimer's Disease, For Clinical Development And Commercialization, If Approved
$Acumen Pharmaceuticals(ABOS.US)$announced that it has entered into a senior secured loan and security agreement with K2 HealthVentures, a healthcare-focused specialty finance company.
$Acumen Pharmaceuticals(ABOS.US)$Just off ATL ( you know how i likes me some bottom bouncers, hehehe ) Earnings out Monday 11/13/23 BMO! But mainly for the following! Phase 1 data on ACU193/INTERCEPT-AD was very promising! The Recent collaboration & License agreement with HALOZYME Could make this Alzheimer’s treatment a game changer for patients by allowing the delivery of the drug Subcutaneously instead of IV? Which would be much more convenient and less inva...
$Acumen Pharmaceuticals(ABOS.US)$Acumen Pharmaceuticals, Inc. And Halozyme Enter Global Collaboration And License Agreement To Develop Subcutaneous Formulation Of ACU193 With ENHANZE Technology
Acumen Pharmaceuticals股票討論區
NEWS
Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting
Sabirnetug demonstrated a favorable safety profile with low incidence of ARIA-E in early AD participants.
Target engagement with AβOs in cerebrospinal fluid increased in a dose-dependent manner, suggesting active removal of target from the brain.
Sabirnetug treatment led to changes in CSF and plasma bio...
Getting ducks in a row just in case! LIKE the optimism
slowly moving up
Hmm! A bit more I can add to my liking!
Longer term swing/But could be DT?
News
AH + 7/18 Watchlist ⚡️⚡️
Current watch ⚡️⚡️
Let’s go
暫無評論